Hepatitis C prevalence in England remains low and varies by ethnicity: An updated evidence synthesis

European Journal of Public Health

Volumn 22, Issue 2, 2012, Pages 187-192

  Harris, Ross J ^a   Ramsay, Mary ^a   Hope, Vivian D ^a,b   Brant, Lisa ^a   Hickman, Matthew ^c   Foster, Graham R ^d   De Angelis, Daniela ^a,e  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; ASIA; BAYES THEOREM; BLOOD; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR; STATISTICS; SUBSTANCE ABUSE; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ASIA; BAYES THEOREM; ENGLAND; ETHNIC GROUPS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 80053602671     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckr083     Document Type: Article

References (39)

1. Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J Roy Stat Soc Ser C-Appl Stat 2005;54:385-404. (Pubitemid 40306661)
2. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36(5 Suppl 1):S35-46. (Pubitemid 35253462)
3. Hickman M, Higgins V, Hope V, et al. Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. J Epidemiol Community Health 2004;58:766-71. (Pubitemid 39127887)
4. Aust R, Sharp C, Goulden C. Prevalence of Drug Use: Key Findings from the 2001/2002 British Crime Survey. London: Home Office Research, Development and Statistics Directorate, 2002.
5. Gungabissoon U, Balogun MA, Ramsay ME. Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004. Epidemiol Infect 2007;135:541-8. (Pubitemid 46647391)
6. The Hepatitis C trust, University of Southampton. The UK vs. Europe: Ready to Fight Back? London: The Hepatitis C Trust, 2007.
7. Sweeting MJ, De Angelis D, Hickman M, Ades AE. Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit. Biostatistics 2008;9:715-34.
8. De Angelis D, Sweeting M, Ades A, et al. An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales. Stat Methods Med Res 2009;18:361-79.
9. Safe Supplies: Testing the Nation. Annual Review from the NHS Blood and Transplant/Health Protection Agency Centre for Infections Epidemiology Unit, 2009. London: Health Protection Agency, 2010.
10. Office for National Statistics. Population Estimates by Ethnic Group for England and Wales. Available at: http://www.statistics.gov.uk/statbase/product. asp?vlnk=14238 (13 January 2011, date last accessed).
11. WHO. Weekly Epidemiological Record. Geneva: WHO, 1999.
12. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology 2007;46:1034-40. (Pubitemid 350144768)
13. Denis F, Ranger-Rogez S, Alain S, et al. Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years. Eur J Epidemiol 2004;19:973-8. (Pubitemid 39434555)
14. Health Protections Agency. Hepatitis C in the UK 2009. London: Health Protection Agency Centre for Infections, 2009.
15. Roe S, Man L. Drug Misuse Declared: Findings from the 2006/06 British Crime Survey. London: Home Office Research, Development and Statistics Directorate, 2006.
16. Becker J, Roe S. Drug Use Among Vulnerable Groups of Young People: Findings from the 2003 Crime and Justice Survey. London: Home Office Research, Development and Statistics Directorate, 2005.
17. Hickman M, Vickerman P, Macleod J, et al. Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007;102:597-606. (Pubitemid 46398826)
18. Singleton N, Bumpstead R, O'Brien M, et al. Psychiatric morbidity among adults living in private households, 2000. Int Rev Psychiatry 2003;15:65-73. (Pubitemid 36363527)
19. Johnson AM, Wadsworth J, Wellings K, Field J. Sexual attitudes and lifestyles. Oxford: Blackwell Scientific Press, 1994.
20. Office for National Statistics. Mid-year Population Estimates: Quinary Age Groups and Sex for Local Authorities in England and Wales; Estimated Resident Population Based on the 2001 Census. London: Office for National Statistics, 2008.
21. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and Hepatitis Infections in the United Kingdom 2001. London: Department of Health, 2002.
22. Balogun MA, Ramsay ME, Parry JV, et al. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect 2003;79:301-6. (Pubitemid 37026348)
23. Balogun MA, Ramsay ME, Parry JV, et al. The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England. Epidemiol Infect 2000;125:705-12. (Pubitemid 32156859)
24. Ades AE, Parker S, Walker J, et al. HCV prevalence in pregnant women in the UK. Epidemiol Infect 2000;125:399-405.
25. Uddin G, Shoeb D, Solaiman S, et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat 2010;17:327-35.
26. Tilling K, Sterne JA. Capture-recapture models including covariate effects. Am J Epidemiol 1999;149:392-400. (Pubitemid 29302113)
27. Hay G, Gannon M, MacDougall J, et al. Capture-recapture and anchored prevalence estimation of injecting drug users in England: national and regional estimates. Stat Methods Med Res 2009;18:323-39.
28. King R, Bird SM, Brooks SP, et al. Prior information in behavioral capture-recapture methods: demographic influences on drug injectors' propensity to be listed in data sources and their drug-related mortality. Am J Epidemiol 2005;162:694-703. (Pubitemid 41437369)
29. Office for National Statistics. Annual Population Survey. Available at: http://www.ons.gov.uk/about-statistics/user-guidance/lm-guide/sources/household/ aps/index.html (13 January 2011, date last accessed).
30. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006;13:34-41.
31. Sweeting M, De Angelis D, Ades A, Hickman M. Estimating the prevalence of ex-injecting drug use in the population. Stat Methods Med Res 2009;18:381-95.
32. Spiegelhalter D, Thomas A, Best N, Lunn D. WinBUGS Version 1.4 User Manual. Cambridge: MRC Biostatistics Unit, 2003.
33. Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graphical Stat 1998;7:434-55. (Pubitemid 128635035)
34. Hope V, Parry J, Marongiu A, Ncube F. Hepatitis C infection among recent initiates to injecting in England 2000 to 2008: Is a national hepatitis C action plan making a difference? J Viral Hepat 2011;18: in press, doi: 10.1111/j.1365-2893.2010.01415.x.
35. English L. Treatment and care for older drug users. In: Eaton G, Davies C, English L, et al, editors. National Report to the EMCDDA by the Reitox National Focal Point United Kingdom: New Developments, Trends and In-depth Information on selected issues: 2009. London: UK Focal Point on Drugs, 2009.
36. Sweeting MJ, Hope VD, Hickman M, et al. Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again? Am J Epidemiol 2009;170:352-60.
37. Kimber J, Copeland L, Hickman M, et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ 2010;341:c3172.
38. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62. (Pubitemid 29384163)
39. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol 2010;82:546-55.